Corticosteroid overuse in adults with immune thrombocytopenia: Cause for concern
Abstract Corticosteroids remain a crucial component of first‐line therapy for immune thrombocytopenia (ITP) due to low cost, high initial response rates, and acceptable short‐term tolerability. However, extended and recurrent use of corticosteroids is associated with substantial toxicity. Survey stu...
Main Authors: | Adam Cuker, Howard A. Liebman |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-08-01
|
Series: | Research and Practice in Thrombosis and Haemostasis |
Subjects: | |
Online Access: | https://doi.org/10.1002/rth2.12592 |
Similar Items
-
Overuse of corticosteroids in patients with immune thrombocytopenia (ITP) between 2011 and 2017 in the United States
by: Adam Cuker, et al.
Published: (2023-05-01) -
Serum thrombopoietin and cMpl expression in thrombocytopenia of different etiologies
by: Fabrizio Vianello, et al.
Published: (2014-03-01) -
Use of thrombopoietin receptor agonists in childhood immune thrombocytopenia
by: Angelica Maria Garzon, et al.
Published: (2015-08-01) -
Association between megakaryocyte abnormalities on bone marrow smear and response to thrombopoietin receptor agonists in adult patients with primary immune thrombocytopenia
by: Ondine Walter, et al.
Published: (2022-11-01) -
Recent advances in the mechanisms and treatment of immune thrombocytopenia
by: Drew Provan, et al.
Published: (2022-02-01)